Sean E. Aeder

Array ( [id] => 6126655 [patent_doc_number] => 20110086404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'METHOD FOR MONITORING, DIAGNOSING, AND SCREENING CANCER THROUGH MEASURING THE CONCENTRATION OF DES-R PROTHROMBIN ACTIVATION PEPTIDE FRAGMENT F2 (DES-R F2) IN A SERUM' [patent_app_type] => utility [patent_app_number] => 12/993198 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7368 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086404.pdf [firstpage_image] =>[orig_patent_app_number] => 12993198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580531 [patent_doc_number] => 20090175877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'METHODS OF INHIBITING METASTASIS' [patent_app_type] => utility [patent_app_number] => 12/402851 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10364 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175877.pdf [firstpage_image] =>[orig_patent_app_number] => 12402851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355019 [patent_doc_number] => 20090186363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR' [patent_app_type] => utility [patent_app_number] => 12/402434 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 67867 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186363.pdf [firstpage_image] =>[orig_patent_app_number] => 12402434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435394 [patent_doc_number] => 08283162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Antibodies relating to PIVKAII and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/401361 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22196 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12401361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533034 [patent_doc_number] => 20090232822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'LUNG DISEASE TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/400212 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43118 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232822.pdf [firstpage_image] =>[orig_patent_app_number] => 12400212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6185038 [patent_doc_number] => 20110123997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'MOLECULAR DIAGNOSIS AND CLASSIFICATION OF MALIGNANT MELANOMA' [patent_app_type] => utility [patent_app_number] => 12/920957 [patent_app_country] => US [patent_app_date] => 2009-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 32573 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123997.pdf [firstpage_image] =>[orig_patent_app_number] => 12920957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282689 [patent_doc_number] => 08216789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Diagnostic panel of cancer antibodies and methods for use' [patent_app_type] => utility [patent_app_number] => 12/394922 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 15428 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12394922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4433913 [patent_doc_number] => 07897740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Secreted protein called 36P6D5 characteristic of tumors' [patent_app_type] => utility [patent_app_number] => 12/393936 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 33232 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897740.pdf [firstpage_image] =>[orig_patent_app_number] => 12393936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6584154 [patent_doc_number] => 20100047787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'PROSTATE CANCER SURVIVAL AND RECURRENCE' [patent_app_type] => utility [patent_app_number] => 12/391224 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 13492 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047787.pdf [firstpage_image] =>[orig_patent_app_number] => 12391224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580894 [patent_doc_number] => 20090176240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'MN/CA IX and Cancer Prognosis' [patent_app_type] => utility [patent_app_number] => 12/371881 [patent_app_country] => US [patent_app_date] => 2009-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14063 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176240.pdf [firstpage_image] =>[orig_patent_app_number] => 12371881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7739983 [patent_doc_number] => 08105777 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-01-31 [patent_title] => 'Methods for diagnosis and/or prognosis of colon cancer' [patent_app_type] => utility [patent_app_number] => 12/370264 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 30869 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 262 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/105/08105777.pdf [firstpage_image] =>[orig_patent_app_number] => 12370264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355022 [patent_doc_number] => 08673555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Detecting neoplasm' [patent_app_type] => utility [patent_app_number] => 12/866558 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15616 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12866558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514756 [patent_doc_number] => 20090215063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Phosphospecific PAK antibodies and diagnostic kits' [patent_app_type] => utility [patent_app_number] => 12/369567 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6953 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215063.pdf [firstpage_image] =>[orig_patent_app_number] => 12369567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943442 [patent_doc_number] => 20110104062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Biomarkers for Head-And-Neck Cancers and Precancers' [patent_app_type] => utility [patent_app_number] => 12/866567 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 67456 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104062.pdf [firstpage_image] =>[orig_patent_app_number] => 12866567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533017 [patent_doc_number] => 20090232805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'METHODS OF INHIBITING RECEPTOR TYROSINE KINASES WITH AN EXTRACELLULAR ANTAGONIST AND AN INTRACELLULAR ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 12/361350 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8024 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232805.pdf [firstpage_image] =>[orig_patent_app_number] => 12361350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4478308 [patent_doc_number] => 07906635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer' [patent_app_type] => utility [patent_app_number] => 12/354641 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 47 [patent_no_of_words] => 310564 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906635.pdf [firstpage_image] =>[orig_patent_app_number] => 12354641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552971 [patent_doc_number] => 20090286957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 12/350814 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 291924 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286957.pdf [firstpage_image] =>[orig_patent_app_number] => 12350814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385668 [patent_doc_number] => 20090226913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'IDENTIFICATION OF CANCER BIOMARKERS AND PHOSPHORYLATED PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/340341 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29385 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226913.pdf [firstpage_image] =>[orig_patent_app_number] => 12340341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563672 [patent_doc_number] => 20090136524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS' [patent_app_type] => utility [patent_app_number] => 12/340211 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 34871 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136524.pdf [firstpage_image] =>[orig_patent_app_number] => 12340211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6143124 [patent_doc_number] => 20110129844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'Use of Activating Transcription Factor-2 (ATF2) for Detecting Skin Cancer' [patent_app_type] => utility [patent_app_number] => 12/810008 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13683 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129844.pdf [firstpage_image] =>[orig_patent_app_number] => 12810008 [rel_patent_id] =>[rel_patent_doc_number] =>)